Furthermore, Eca109 cells were treated with exogenous CCL17 or co-treated with exogenous CCL17 and CCR4 antagonist AZD2098 in order to further expound the oncogenic role of CCL17 in ESCC and to thoroughly elucidate the underlying mechanisms. Here, CCR4 is linked to esophageal squamous cell carcinoma.